# Librata Endometrial Ablation Device Treatment to Reduce Menstrual Blood Loss in Sites Across the United Kingdom

> **NCT02971189** · NA · UNKNOWN · sponsor: **Birmingham Women's NHS Foundation Trust** · enrollment: 40 (estimated)

## Conditions studied

- Heavy Menstrual Bleeding

## Interventions

- **DEVICE:** Librata Endometrial Ablation

## Key facts

- **NCT ID:** NCT02971189
- **Lead sponsor:** Birmingham Women's NHS Foundation Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-12
- **Primary completion:** 2017-01
- **Final completion:** 2017-08
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2016-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02971189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02971189, "Librata Endometrial Ablation Device Treatment to Reduce Menstrual Blood Loss in Sites Across the United Kingdom". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT02971189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*